Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001794362-26-000004

Chief Financial Officer acquired 11,712 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tressler Nick B. Chief Financial Officer 2026-06-30 Grant or award +11,712 $0.19 $2,250 11,712 D
Loading xslF345X06/form4-07022026_080720.xml…